Sexual Dysfunction, Cardiovascular Risk and Effects of Pharmacotherapy
- 26 January 2018
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Vascular Pharmacology
- Vol. 16 (2), 130-142
- https://doi.org/10.2174/1570161115666170609101502
Abstract
Background: Sexual dysfunction affects millions of people with an increasing prevalence, worldwide. The pathophysiology of the disease shares several similarities with cardiovascular disease (CVD), including atherosclerosis, endothelial dysfunction, structural vascular damage and subclinical inflammation. Erectile dysfunction (ED) and female sexual dysfunction are common among patients with CVD and risk factors such as hypertension, diabetes, obesity and metabolic syndrome. Given the common pathogenesis of the diseases, ED is an independent prognostic factor of future ED events. Patients with overt ED or risk factors are usually treated with several drugs for the management of these conditions. Several of these drugs have been evaluated for their effect on sexual activity. Results and Conclusion: Among the antihypertensive drugs, diuretics and beta-blockers seem to exert a detrimental impact on sexual function, with nebivolol being the only beta-blocker with favorable properties through an increase in nitric oxide bioavailability. In contrast, renin-angiotensin system inhibitors and calcium-channel blockers have a neutral effect on sexual activity. Hypoglycemic drugs have been less evaluated in the ED setting, with metformin, pioglitazone and liraglutide presenting favorable results. Statins on the other hand have not provided consistent results with observational studies suggesting a detrimental role in sexual activity and a few randomized studies indicating a neutral or even beneficial effect on erectile function.Keywords
This publication has 165 references indexed in Scilit:
- Smoking and Risk of Erectile Dysfunction: Systematic Review of Observational Studies with Meta-AnalysisPLOS ONE, 2013
- Erectile Dysfunction Severity as a Risk Marker for Cardiovascular Disease Hospitalisation and All-Cause Mortality: A Prospective Cohort StudyPLoS Medicine, 2013
- Male erectile dysfunction and microalbuminuria in adult nigerians with essential hypertensionNorth American Journal of Medical Sciences, 2013
- Association between smoking cessation and sexual health in menBJU International, 2011
- Effect of Angiotensin II and its Receptor Antagonists on Human Corpus Cavernous Contractility and Oxidative Stress: Modulation of Nitric Oxide Mediated RelaxationJournal of Urology, 2011
- Effect of Intensive Glycemic Therapy on Erectile Function in Men With Type 1 DiabetesJournal of Urology, 2011
- Hypertension and sexual dysfunction: time to actJournal of Hypertension, 2011
- Erectile Dysfunction and MortalityThe Journal of Sexual Medicine, 2009
- Is Hyperlipidemia or its Treatment Associated with Erectile Dysfunction?: Results from the Boston Area Community Health (BACH) SurveyThe Journal of Sexual Medicine, 2009
- Prevalence of Asymptomatic Coronary Artery Disease in Men with Vasculogenic Erectile Dysfunction: A Prospective Angiographic StudyEuropean Urology, 2005